Health
Despite Drug Industry Claims, Higher List Prices Do Mean Higher Out-of-Pocket Costs for Many Patients – Gizmodo Australia
New research suggests that as the list price of brand name drugs rise, so do out-of-pocket medical costs for these drugs — at least for some patients. This is counter…
New research suggests that as the list price of brand name drugs rise, so do out-of-pocket medical costs for these drugs at least for some patients. This is counter to a common industry claim that patients arent affected by list price increases. The study found a link between list prices rising and out-of-pocket increases among people with private insurance plans that mandated deductibles and coinsurance. These patients also didnt seem to benefit from rebates passed down by drug makers to insurance…
Continue Reading
